We examined the ontogeny of mRNA levels of IGF-I and -II, IGF type 1 (IGFI-R) and type II receptors (IGFII-R), IGF binding protein-1 and -3 (IGFBP-1 and -3), GH receptor (GHR), and tissue concentrations of IGF and IGFBP in the pancreas of pigs. Tissues were collected from fetuses at 90 and 110 d of gestation and from pigs at 1, 21, 90 and 180 d of age. Northern blots were performed using total RNA hybridized with 32 P-labeled cDNA probes (human IGF-I and human IGFI-R) and cRNA probes (rat IGF-II, human IGFII-R, human IGFBP-1, pig IGFBP-3, and pig GHR). There were two accelerated growth stages of the pancreas: the first one at 90 d of fetal life, which is characterized by cell hyperplasia (high ratio of DNA to body weight), and the second one at postnatal 90 d, which is attributed to cell hypertrophy (high ratios of pancreatic weight, RNA, and protein to DNA). The level of IGF-II mRNA and its tissue concentration were predominant during fetal life and low thereafter. The IGF-I mRNA level was high during fetal and early postnatal life and decreased thereafter. Messenger RNA levels of IGFI-R, IGFBP-3, and GHR and concentrations of IGFBP-1 and -2 were abundant during fetal and early postnatal life. In conclusion, IGF may be involved in various physiological periods of pancreatic development in pigs.
Introduction
Information on IGF in regulating pancreatic development has been derived largely from rodents. It was reported that IGF stimulate DNA synthesis in isolated fetal rat islets of Langerhans (Hogg et al., 1993) . However, only limited data are available on tissue concentration and content of IGF mRNA in pancreas of large mammals during development.
Messenger RNA for IGF-I and -II were found in various tissues from rats (Murphy et al., 1987) and pigs (Lee et al., 1993; Peng et al., 1996a) . The IGFI receptor ( R) was also found on rat pancreatic A and B cells (Van Schravendijk et al., 1987) . Tissue mRNA levels of IGF-I and -II were developmentally regulated in rats and pigs. Various forms of IGF specific binding proteins ( IGFBP) have been identified from pig serum (Lee et al., 1991a) . In humans, IGFBP-1, -2, and -3 were found in various fetal tissues, including the pancreatic endocrine tissue (Hill and Clemmons, 1992) . Exogenous IGFBP-1 and -2 can potentiate the ability of IGF-I or IGF-II to stimulate DNA synthesis by isolated fetal rat islets of Langerhans (Hogg et al., 1993) . In rats, pancreatic IGFBP-1 and -2 mRNA increased from late fetal to early postnatal life, whereas mRNA for IGFBP-3 and -4 were predominant after birth (Hogg et al., 1994) .
Growth hormone plays an important role in postnatal development. Growth hormone acts via its mem-brane-bound receptor, and mRNA of GH receptor ( GHR) has been found in fetal rat tissues (Walker et al., 1992) and in liver and muscle from pigs (Brameld et al., 1996) .
The objectives of the present study were 1 ) to characterize the developmental pattern of pancreatic growth, 2 ) to determine mRNA levels of IGF, IGFBP, IGFR, and GHR and tissue concentrations of IGF and IGFBP in the pancreas during fetal and postnatal development, and 3 ) to investigate potential relationships that might exist between pancreas growth, mRNA levels, and tissue concentrations of IGF and IGFBP in pigs.
Materials and Methods

Tissue Preparation
Yorkshire purebred fetuses from 90 ( F90) and 110 ( F110) d of gestation and pigs of postnatal 1 ( P1) , 21 ( P21) , 90 ( P90) , and 180 ( P180) d of age were used. Ages of the fetuses were determined according to the sows' mating dates. For each age, two males and two females were obtained from the same litter, and three litters were used at each age. Pigs, pregnant and lactating sows, with the exception of fetuses, were deprived of feed for 16 h before slaughter. Animals were slaughtered (stunning and exsanguination) according to the recommended code of practice for the care and handling of farm pigs (Agriculture and AgriFood Canada, 1993) . After laparotomy, the uterus was gradually opened, and the fetuses were removed. The body weights (mean ± SE) at slaughter were .61 ± .01, 1.15 ± .05, 1.48 ± .03, 6.08 ± .46, 28.9± 2.12, and 95.4 ± 3.48 kg for F90, F110, P1, P21, P90, and P180, respectively. Immediately after exsanguination, the pancreas was removed by dissection and weighed. Tissue samples used for Northern blot analysis and RIA were frozen in liquid nitrogen and stored at −80°C until they were analyzed. Fresh tissue samples were used for DNA, RNA, and protein determination.
Measurement of DNA, RNA, and Protein
Tissues (150 mg) were homogenized and precipitated in .7 N perchloric acid ( PCA) for DNA, RNA, and protein determinations. Protein was analyzed by the method of Lowry et al. (1951) with BSA as a standard. The DNA and RNA were extracted and measured according to the methods previously described (de Passillé et al., 1989) .
Radioimmunoassay
Pancreas IGF-I and -II were quantified with RIA using methodologies previously described (Abribat et al., 1990; Lee et al., 1991b) . The pancreatic tissue was homogenized in freshly prepared 3.3 M formic acid containing .5% Tween 20 (1:4 wt vol) at pH 2 and centrifuged at 40,000 × g for 15 min at 4°C to dissociate the IGF-IGFBP complex. A 150-mL aliquot of each sample was heated at 90°C for 30 min, 350 mL of acetone was then added, and the mixture was thoroughly vortexed followed by centrifugation at 3,500 × g for 15 min at 4°C. The supernatant was neutralized with the RIA buffer and used directly for IGFs measurement.
Recombinant human IGF-I and -II (Bachem California, Torrance, CA) were used for iodination and standards. Anti-human IGF-I antibodies were kindly provided by E. Underwood and J. J. Van Wyk (University of North Carolina, by the National Institute of Diabetes, Digestive and Kidney Disease through the National Hormone and Pituitary Program). Monoclonal anti-human IGF-II was purchased from Amano International Enzyme (Troy, VA). The RIA was performed under equilibrium conditions using IGF-I or -II radioiodionated with the conventional chloramine T method. The RIA buffer consisted of 30 mM phosphate buffer, pH 7.4, containing .02% protamine sulphate (Grade II), 10 mM EDTA, .02% sodium azide, and .25% BSA (all buffer components from Sigma Chemical, St Louis, MO). Diluted sample extract or standard (100 mL ) was incubated at 4°C for 24 h with 100 mL of specific antibody (final dilution 1/ 20,000 and 1/50,000 for the anti IGF-I and IGF-II antisera, respectively, 100 mL [ 125 I] IGF-I or -II (10,000 cpm), and 200 mL of RIA buffer. The binding reaction was stopped by precipitation (24 h at 4°C) with 100 mL of the second antibody (goat anti-rabbit IgG for IGF-I and goat anti-mouse IgG for IGF-II purchased from Linco Research, St. Louis, MO), and the pellets were evaluated in a gamma counter (Beckman LS 580, Beckman Instruments, Scientific Instruments Division, Irvine, CA) after centrifugation. In our assay conditions, ED 50 from standard curves were 60 ± 8 and 86 ± 10 pg/tube for IGF-I and -II, respectively (means ± SD of 10 replications). Intraand interassay CV were 4 and 13% and 3 and 12% for IGF-I and IGF-II, respectively.
Western Ligand Blotting for IGFBP
Pancreatic acid extracts were subjected to Western ligand blot analysis as described by Hossenlopp et al. (1986) . Initial experiments showed that neutralized acid extracts gave results similar to extracts performed in neutral conditions. Therefore, the 40,000 × g supernatants of the formic acid extracts (described in the previous section) were neutralized with an equal volume of 2 M Tris buffer, pH 8.5, then diluted in SDS nonreducing sample buffer and loaded onto a 12% SDS polyacrylamide gel and electrophoresed. Proteins were then transferred to nitrocellulose (BioRad, Richmond, CA) at 15 V overnight in a Transblot Cell (BioRad). The blotted membranes were washed with Tris buffer saline ( TBS; .1 M Tris, pH 7.4, .15 M NaCl, and .05% sodium azide), containing sequentially 3% NP 40 for 30 min, 1% BSA for 2 h, and .1% Tween 20 for 10 min and then incubated with [ 125 I] IGF-I (1.4 × 10 5 cpm/ mL) in 30 mL TBS, .1% BSA overnight at 4°C. Membranes were washed twice for 15 min in TBS, .1% Tween 20, three times for 15 min in TBS, dried, and exposed to x-ray films in the presence of an intensifying screen for 3 d at −80°C. For quantitative analysis, bands of the membrane corresponding to those on autoradiograms were cut and evaluated in a gamma counter. For each IGFBP, data were expressed as counts per minute.
RNA Preparation
Total RNA from the pancreas was extracted with the method described by Chirgwin et al. (1979) . Tissues were homogenized in 4 M guanidinium thiocyanate using a polytron homogenizer. Supernatants were used for precipitation of RNA in 100% ethanol and 2 M potassium acetate at −20°C. After centrifugation, the RNA pellets were dissolved in 7 M guanidine hydrochloride. The RNA was precipitated again and quantified by measuring its absorbance at 260 nm.
Preparation of Probes
A human IGF-I cDNA, which corresponds to a 659-bp cDNA EcoRI fragment (Jansen et al., 1983) , and a human IGF-IR cDNA (Ullrich et al., 1986) corresponding to a 700-bp cDNA EcoRI fragment were used. The cDNA probes were labeled with [ 32 P]dCTP (3,000 Ci/mmol; Amersham Canada Limited, Oakville, Ont., Canada) by random priming using a commercial kit (Megaprime DNA labelling System, Amersham Canada Limited).
Rat IGF-II, human IGFBP-1, porcine IGFBP-3, and human IGFII-R complementary RNA ( cRNA) probes were transcribed from a 720-bp BamHI cDNA fragment (Ueno et al., 1988) , a 1,443-bp EcoRI cDNA fragment (Julkunen et al., 1988) , a 595-bp EcoRISmaI cDNA fragment (Shimasaki et al., 1990) , and a 695-bp KpnI-Hind III (Morgan et al., 1987) fragment, respectively. The cDNA fragments were inserted into the pBluescript KSII+ plasmid vector. The inserts were sequenced using a T7 Sequencing™ Kit (Pharmacia Biotech, Piscataway, NJ) to check the orientation of the cDNA. The templates were linearized with EcoRI for IGF-II, HindIII for IGFBP-1, SamI for IGFBP-3, and KpnI for IGFII-R and then used in a T7 transcription Riboprobe System (Promega, Madison, WI).
The GHR probe was prepared by RT-PCR. The GHR primers were designed according to known regions of the pig GHR cDNA sequence (Cioffi et al., 1990) . The upstream primer ( 5′-ATCCCGCGGAACCACCTCC-CAATGCAGATGTTC-3′) is identical to nucleotide 545 to 568, and the downstream primer ( 5′-ATCTC-TAGATGGCGCTAGACGTGATTCAACCTC-3′) represents the reverse complement of nucleotides 1,669 to 1692. An EcoRV site for upstream primer and a XbaI site for downstream primer were created by addition of nine nucleotides. This primer pair predicts a 1,166-bp fragment. First-strand cDNA was synthesized from total RNA ( 6 mg ) using a "SuperScript™ Preamplification System for First Strand cDNA Synthesis" kit (Gibco BRL, Life Technologies, Burlington, ON) and 500 ng of oligo(dT) 12−18 primer in a total reaction volume of 30 mL. An aliquot of 3 mL was subjected to PCR amplification using a PTC-100™ Programmable Thermal Controller (MJ Research, Watertown, MA). The reaction mix contained 3 mL of reverse transcription mixture, 30 pmol of each primer, 1× PCR buffer (Pharmacia Biotech, Piscataway, NJ), .35 mM dNTP, and water to 100 mL. After overlaying with three drops of light mineral oil (Sigma, St. Louis, MO), the reactions were heated to 94°C for 2 min before the addition of 4 U of the Taq polymerase (Pharmacia Biotech). The amplification profile comprised 35 cycles: 94°C for .75 min (dissociation), 55°C for 1.25 min (annealing), and 72°C for 2.5 min (extension). The final cycle included a further 5 min at 72°C for complete strand extension. A PCR amplified cDNA fragment of the predicted length was inserted into the pBluescript KSII+ plasmid vector. The authenticity of the cDNA clone was verified by sequencing using a T7 Sequencing™ kit (Pharmacia Biotech). The template was linearized with EcoRV and then used in a T7 transcription Riboprobe System (Promega) to synthesize the cRNA probe.
Northern Blot Analysis
The procedure for Northern blot was described by Lehrach et al. (1977) with some modifications. Briefly, 20 mg of total RNA was fractionated in a 1% agarose gel containing 2.2 M formaldehyde before transfer to nylon membranes (Nytran, Schleicher and Schuell, Keene, NH). For RNA probes, membranes were prehybridized for 4 h in a solution of 50% formamide, 5 × SSC, 50 mM Hepes, pH 6.8, 2 mM EDTA, pH 8.0, 5× Denhardt's, 1% SDS, and 200 mg/mL of salmon sperm DNA at 65°C. They were then hybridized in the same solution overnight at 65°C with cRNA riboprobes (rat IGF-II, human IGFII-R, human IGFBP-1, porcine IGFBP-3, and pig GHR), which were labeled with [ 32 P]dUTP.
For DNA probes, membranes were prehybridized for 15 min in a solution (Rapid-hyb buffer, Amersham Canada Limited) at 65°C and then hybridized in the same solution for 2 h at 65°C with cDNA probes labeled with [ 32 P]dCTP (human IGF-I and human IGF-I receptor). Membranes were then washed with .1 × SSC/ .1% SDS twice, 30 min at 85°C for RNA probes and at 60°C for cDNA probes, and exposed to Kodak films (Eastman Kodak Company, Rochester, NY) with an intensifying screen at −80°C. The blots were reprobed with 18S ribosomal [ 32 P]cDNA probe as a control to quantify RNA loading and transfer. The size of RNA transcript was evaluated according to the position of 18S and 28S rRNA or RNA ladder.
Autoradiograms were scanned using a densitometer (BIO-RAD Imaging Densitometer Model GS-670, Biorad Laboratories, Mississauga, Ont., Canada). The relative density of the transcript is expressed as arbitrary optical units. To correct for the possible difference in loading of total RNA in Northern blot, a ratio of the relative density of each specific transcript of growth factors to the density of the 18S ribosomal RNA band was calculated before statistical analysis was performed.
Statistical Analysis
We ran analyses of variance for the following variables: body weight, organ weight, and tissue content of RNA, DNA, and protein. We used age of pig as the main effect, sow within each age as the first error term, sex of pigs as a split effect, and age × sex interaction. The different ages were compared using a priori comparisons. The following comparisons were used: 1 ) fetuses (F90 + F110) vs suckling pigs (P1 + P21), 2 ) suckling vs postweaning pigs (P90 + P180), 3 ) within fetal ages: F90 vs F110, 4 ) within suckling ages: P1 vs P21, and 5 ) within postweaning ages: P90 vs P180. For the Northern blot analysis we used membrane and age as main effects and the membrane × age interaction as the error term for age. All variables were submitted to an analysis of variance using the GLM procedure of SAS software (1985) . Data were considered significantly different if a probability value was ≤.05.
Results
Development of the Pancreas
Two fast-growing periods of the pancreas in terms of organ weight to body weight were observed at fetal F90 and P90; weights were 23 and 31% higher than average values, respectively (Figure 1a) . The highest ratio of total pancreatic DNA to body weight was observed at F90 and decreased ( P < .001) to a lower level thereafter (Figure 1b) . The ratios of pancreatic weight to DNA, RNA to DNA, and protein to DNA were the lowest ( P < .001) during fetal life and increased thereafter (Figure 1c, d , and e).
Pancreatic IGF, IGFBP, and IGFR and GHR mRNA Levels
One major IGF-I mRNA transcript of approximately 7.8 kb was detected in the pancreas (Figure 2 , top panel). High levels of IGF-I mRNA were observed during fetal and suckling periods (P1 and P21) and decreased ( P = .001) after weaning (P90 and P180) (Figure 2, bottom panel) . Messenger RNA for IGFI-R was present as a single 11-kb transcript (Figure 3, top  panel) , but IGFII-R mRNA was undetectable in the pancreas (data not shown). Pancreatic mRNA of IGFI-R was relatively abundant during the fetal and neonatal life and was low from P21 to P180 ( P = .05, Figure 3 , bottom panel). A single IGF-II mRNA transcript of approximately 2.2 kb was found in the pancreas (Figure 4, top panel) . The highest level of IGF-II mRNA was observed during fetal life and decreased ( P < .05) at birth (Figure 4, bottom panel) . A 1.8-kb IGFBP-1 mRNA transcript was found abundant in the fetal liver, but it is low in the pancreas ( Figure 5) . A single 2.8-kb mRNA transcript for IGFBP-3 was detected in the pancreas (Figure 6, top  panel) . A high level of IGFBP-3 mRNA occurred from fetal to early postnatal life and declined ( P = .003) thereafter ( Figure 6 , bottom panel). One major transcript of 4.6 kb for GHR was found in the pancreas (Figure 7 , top panel) at a relatively high level in fetuses and newborns and was low ( P < .05) from P21 to P180 (Figure 7 , bottom panel).
Pancreatic IGF and IGFBP Concentrations
The pancreatic concentration of IGF-I was low in fetuses and newborns then peaked in pigs of 21 d of age (17-fold higher in P21 compared to F90, P < .001) followed by a relatively low level thereafter ( Figure  8 ). However, IGF-II concentration was high during fetal life and decreased ( P < .001) with advancing age (Figure 8 ).
Western blotting of IGFBP in pancreas homogenates showed two major bands (Figure 9 , top panel). One band was present at 32.5 kDa, corresponding to IGFBP-2, and another at 27.5 kDa, corresponding to IGFBP-1, which was the predominant one in the pig pancreas. Contents of IGFBP-1 and -2 shared a similar pattern, with the highest levels ( P < .001) present in fetuses then followed by a marked decrease (IGFBP-1, P < .001; IGFBP-2, P = .001) during the postnatal period ( Figure 9 , bottom panel). The concentrations of IGFBP-3 and -4 were barely detected (data not shown).
No effects of sex and age × sex interaction were observed for any measurements.
Discussion
The results of this study indicate that fast fetal pancreatic growth at F90 is characterized by cell hyperplasia (high DNA/body weight), and a fast postnatal growth at P90 can be attributed to cell hypertrophy (high RNA/DNA and protein/DNA). The rapid growth of the pancreas during fetal life was accompanied by high levels of IGF-II and IGFI-R mRNA and high tissue IGF-II concentration in the pancreas. Mouse embryos carrying null mutations of Figure 1 . Effect of age on (a) pig pancreatic weight, (b) total pig pancreatic DNA to body weight ratio, (c) organ weight, (d) total RNA, and (e) protein to DNA ratios (F: fetus, P: postnatal). Values are means ± SE of 6 to 12 observations at each age (at least one male and one female per litter from three litters were used). Figure 2 . Effect of age on IGF-I mRNA levels in pig pancreas (F: fetus, P: postnatal). Top panel: Representative Northern blot of IGF-I mRNA in pig pancreas during development. Total RNA (20 mg) was applied to a 1% agarose-formaldehyde gel followed by blot hybridization at 65°C using a human IGF-I cDNA probe and washed twice at 60°C with .1× SSC/.1% SDS for 30 min. Autoradiography proceeded for 2 wk at −80°C. The size of the IGF-I mRNA transcript was estimated according to the position of 18S and 28S. Blots were reprobed with an 18S ribosomal 32 P-labeled probe as a control to quantify RNA loading and transfer. Bottom panel: IGF-I mRNA level was evaluated by densitometric scanning of the autoradiography and was expressed in arbitrary optical units as a ratio of the 18S ribosomal RNA signal. One unit is attributed to the maximum ratio and the other values are reported relative to this maximum ratio. Data at each age represent means ± SE obtained from four observations (one male and one female per litter from two litters). Representative Northern blot of IGFI-R mRNA in pig pancreas during development. Total RNA (20 mg) was applied to a 1% agarose-formaldehyde gel followed by blot hybridization at 65°C using a human IGFI-R cDNA probe and washed twice at 60°C with .1× SSC/.1% SDS for 30 min. Autoradiography proceeded for 2 wk at −80°C. The size of the IGFI-R mRNA transcript was estimated according to the position of 19S and 28S. The blots were reprobed with a 18S ribosomal 32 P-labeled probe as a control to quantify RNA loading and transfer. Bottom panel: IGFI-R mRNA level was evaluated by densitometric scanning of the autoradiography and was expressed in arbitrary optical units as a ratio of the 18S ribosomal RNA signal. One unit is attributed to the maximum ratio and the other values are reported relative to this maximum ratio. Data at each age represent means ± SE obtained from four observations (one male and one female per litter from two litters). Total RNA was applied to 1% agarose-formaldehyde gel followed by blot hybridization using a human IGFBP-1 RNA probe (at 65°C). The filter was washed twice at 85°C with .1× SSC/.1% SDS for 30 min. Autoradiography proceeded for approximately 2 wk at −80°C. The size of the transcript was estimated according to an RNA ladder. The blot was reprobed with an 18S ribosomal 32 P-labeled probe as a control to quantify RNA loading and transfer.
the genes encoding IGF-I, -II, and IGFI-R lead to growth deficiency (Baker et al., 1993) . Furthermore, using in situ hybridization, IGF-II mRNA was found to be more abundant than that of IGF-I in human fetal exocrine and endocrine pancreas (Miettinen et al., 1993) . However, in the current study, IGFII-R mRNA was undetected. Baker et al. (1993) reported that in 11-and 12.5-d-old mouse embryos, IGFI-R mediates only mitogenic signaling of IGF-II. After 13.5 d of age, IGFI-R interacts with IGF-I and -II, and IGF-II recognizes an additional unknown receptor that is different from IGFII-R. This suggests that IGF-II regulates pancreatic growth mainly through IGFI-R.
The pancreas IGF-I concentration was the highest at 21 d of age and was preceded by a fast growth period of pancreas at P90. In the present study, we did not evaluate changes of pancreas weight between 21 to 90 d of age, although another fast growth period of this organ occurred at 90 d of age. However, it is possible that pancreatic weight increased before 90 d of age. This assumption is supported by the fact that pancreatic weight (Peng et al., 1996a) and pancreatic enzyme activities increased during the weaning period (Kelly et al., 1991; Lainé et al., 1996) . A role of IGF-I on pancreatic growth was suggested because IGF-I is present in pancreatic A-cells and IGF-II was observed exclusively in B-cells in humans, and the pancreas of dogs and rats (Maake and Reinecke, 1993) . It was also observed that IGF-I mRNA increased fourfold above control values after 3 d in 90% of the Figure 6 . Effect of age on pig pancreatic IGFBP-3 mRNA level (F: fetus, P: postnatal). Top panel: Representative Northern blot of IGFBP-3 mRNA in pig pancreas during development. Total RNA (20 mg) was applied to a 1% agarose-formaldehyde gel followed by blot hybridization at 65°C using a porcine IGFBP-3 cRNA probe and washed twice at 85°C with .1× SSC/ .1% SDS for 30 min. Autoradiography proceeded for 1 wk at −80°C. The size of the IGFBP-3 mRNA transcript was estimated according to the position of 18S and 28S. The blots were reprobed with an 18S ribosomal 32 P-labeled probe as a control to quantify RNA loading and transfer. Bottom panel: IGFBP-3 mRNA level was evaluated by densitometric scanning of the autoradiography and was expressed in arbitrary optical units as a ratio of the 18S ribosomal RNA signal. One unit is attributed to the maximum ratio and the other values are reported relative to this maximum ratio. Data at each age represent means ± SE obtained from four observations (one male and one female per litter from two litters). Figure 7 . Effect of age on pig pancreatic GHR mRNA level (F: fetus, P: postnatal). Top panel: Representative Northern blot of GHR mRNA in pig pancreas during development. Total RNA (20 mg) was applied to a 1% agarose-formaldehyde gel followed by blot hybridization at 65°C using pig GHR cRNA probe and washed twice at 85°C with .1× SSC/.1% SDS for 30 min. Autoradiography proceeded for 2 wk at −80°C. The size of the GHR mRNA transcript was estimated according to an RNA ladder. The blots were reprobed with an 18S ribosomal 32 P-labeled probe as a control to quantify RNA loading and transfer. Bottom panel: GHR mRNA level was evaluated by densitometric scanning of the autoradiography and was expressed in arbitrary optical units as a ratio of the 18S ribosomal RNA signal. One unit is attributed to the maximum ratio and the other values are reported relative to this maximum ratio. Data at each age represent means ± SE obtained from four observations (one male and one female per litter from two litters). Values are means of 6 to 12 observations at each age (at lest one male and one female per litter from three litters were used). IGF-I and IGF-II concentrations were determined by RIA from pancreas homogenates prepared by homogenization of 500 mg to 1 g of tissue in a 1 g to 4 mL ratio wt/vol of 3.3 M formic acid solution to dissociate the IGF-IGFBP complex. pancreatectomy rats (Smith et al., 1991) and highaffinity receptors for IGF-I were present on rat pancreatic A-and B-cells (Van Schravendijk et al., 1987) . We have observed that IGF-I and IGFI-R mRNA were more abundant in the pancreas during fetal life than during postnatal life. However, IGF-I mRNA is less abundant in pancreas than in the other tissues studied (unpublished observations). This is consistent with a study on humans (Bergmann et al., 1995) in which IGF-I mRNA was low in normal pancreas. Therefore, during postnatal life, pancreatic growth of pigs might also be regulated by other growth factors. Cholecystokinin ( CCK) is a gastrointestinal hormone that plays an important role in regulation of pancreatic function and stimulates pancreatic growth (Williams and Blevins, 1993) . However, a previous study indicated that pig pancreatic acinar cells express few CCK A receptors and possess a large majority of the CCK B receptors responsible for their relatively low sensitivity to CCK . However, Vilá et al. (1995) , using a [ 3 H]thymine uptake assay, found that hepatocyte growth factor ( HGF) was the most potent mitogen for normal human pancreas cultures compared to IGF-I and EGF. The HGF receptor has been identified as cmet, which was located to the apical membrane of ductal cells in normal pancreas tissue (Vilá et al., 1995) , suggesting that HGF and c-met may be involved in pancreatic growth. In the present study, IGF-I mRNA was abundant in fetal and early postnatal life and decreased with advancing age; this agrees with our recent observations in rats (Calvo et al., 1997) . However, these observations are not in agreement with the study reported earlier by Hogg et al. (1994) , who showed that pancreatic IGF-I mRNA was predominant during late postnatal development in rats. The reason for such a discrepancy is unknown, but different breeds of rats were used in these studies.
The levels of IGF-I and IGFBP-3 mRNA were high during fetal and neonatal life, IGF-I concentration was low during the same period, and IGFBP-3 was barely detectable over the whole developmental period examined. These results suggest that tissue content of IGF-I and IGFBP-3 may be regulated by posttranscriptional and(or) translational rate of protein synthesis. The levels of IGFs, IGFI-R, and IGFBP-3 and GHR mRNA presented a similar pattern, which was high during the fetal and early postnatal life and declined thereafter, suggesting that accumulation of these mRNA is coordinated in the pancreas. The IGFBP-3 is believed to be the major carrier of IGFs in the serum of adult pigs (Lee et al., 1991a) . In cell culture, intact IGFBP-3 has been shown to directly alter the interaction between IGF-I and its receptor (McCusker et al., 1991) . Furthermore, it was reported that during rat pregnancy, IGFBP-3 decreased in serum, fetus, and reproductive tissues. The decrease in IGFBP-3 was temporally related to the appearance of IGFBP-3 protease activity (Davenport et al., 1992) . The undetected IGFBP-3 level in fetal pancreas may also be due to protein degradation and(or) proteolysis of IGFBP-3, which likely makes more IGF-I and -II available for binding to cell surface receptors.
In the present study, pancreatic GHR mRNA was abundant in fetuses and newborns and decreased thereafter. Messenger RNA for GH receptor/binding protein ( GHR/BP) (Edmondson et al., 1995) and GH receptors (Walker et al., 1992) have been identified in rat fetal tissues, including the pancreas. In the fetal rat pancreas, GHR/BP mRNA was expressed mainly in the epithelium cells of the pancreatic acini, which is adjacent to the connective tissue expressing high level of IGF-I mRNA, thus suggesting a role for GH acting directly and indirectly via IGF-I (Edmondson et al., 1995) . In addition, GH stimulated DNA replication of fetal rat islet cells directly by inducing the local production of IGF-I (Swenne et al., 1987) , an indication that GHR detected in vivo are functional. Together, these findings and data of the present study suggest that IGF-I may act as a mediator of GH involved in fetal pancreatic growth.
Pancreatic IGFBP-1 and -2 contents were high during fetal and early postnatal life, thus paralleling the high levels of pig serum IGFBP-1 and -2 (Lee et al., 1991a) . However, IGFBP-1 mRNA was low in the pancreas during the whole developmental period, suggesting that pancreatic accumulation of IGFBP-1 is regulated at the posttranscriptional level. It is also possible that high pancreatic IGFBP-1 and -2 concentrations come from serum, because these proteins can cross the capillary boundaries and adhere to cell membranes (Bar et al., 1990) . Exogenous IGFBP-1 and -2 could potentiate the ability of IGF-I or -II to stimulate DNA synthesis by isolated fetal rat islets of Langerhans, and IGFBP were themselves released by islets in vitro (Hogg et al., 1993) . These results suggest that IGF and IGFBP may interact to promote cell hyperplasia in fetuses during late gestation.
In summary, pancreatic IGFs and IGFBP concentrations and IGF, IGFBP, and IGFI-R mRNA levels are developmentally regulated. Pancreatic mRNA and tissue concentration of IGF-II were abundant in fetuses and neonatal pigs. The IGF-I mRNA level was high during fetal and early postnatal life. A peak of IGF-I concentration was found at 21 d of age, corresponding to high IGF-I mRNA level and an increase of digestive enzyme activities, suggesting that IGF-I may be involved in pancreatic development.
Implications
We characterized messenger ribonucleic acid expression and tissue concentrations of insulin-like growth factor (IGF) and insulin-like growth factor binding proteins in pancreas of pigs from fetal to postnatal life. The concentrations of IGF-II and IGF-I were high during the fetal and early postnatal periods, respectively, and this supports previous studies on other organs that IGF-II is a fetal growth factor and IGF-I is an active factor for postnatal development. Insulin-like growth factors, IGF-I receptors, IGF binding protein-3, and growth hormone receptor messenger ribonucleic acid levels were abundant during fetal and early postnatal periods, and this seems to indicate that these factors may be involved in early pancreatic growth and development in pigs.
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